• 440 Citations
  • 12 h-Index
19992022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

I maintain national certification as a clinical trial investigator through the Association of Clinical Research Professionals and am routinely invited to speak on the scientific, clinical, and technical merits of clinical research.
My research (over 60 clinical trials serving as sole Principal Investigator) has primarily been in the field of antiretrovirals (anti-HIV medicines) but has also included influenza, hepatitis, and numerous other primary care conditions (diabetes, cholesterol, hypertension, and COPD). My research pursuits remain primarily in the conduct of clinical trials involving new and experimental antiviral medications with an emphasis on pharmacokinetic and pharmacodynamic assessments as well as mechanisms by which tolerability or optimization of outcomes can be achieved. Though not always a senior faculty mentor, historically I have always engaged with collaborative and interdisciplinary teams to achieve results beyond that achievable by single perspectives.

Education/Academic qualification

PharmD, University of Oklahoma Health Science Center

BPharm , University of Louisiana at Monroe

Fingerprint Dive into the research topics where Patrick Clay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
HIV Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Anti-HIV Agents Medicine & Life Sciences
Pharmacists Medicine & Life Sciences
Viral Load Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
HIV Protease Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2022

Research Output 1999 2018

A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV

Clay, P. G., Yuet, W. C., Moecklinghoff, C. H., Duchesne, I., Tronczyski, K. L., Shah, S. & Shao, D., 30 Oct 2018, In : AIDS Research and Therapy. 15, 1, 17.

Research output: Contribution to journalArticleResearchpeer-review

Tablets
Meta-Analysis
HIV
Therapeutics
Cost-Benefit Analysis

Are pharmacists’ interventions worthy of publishing?

Clay, P. G., 1 May 2018, In : Journal of the American Pharmacists Association. 58, 3, 1 p.

Research output: Contribution to journalArticleResearchpeer-review

Pharmacists
22 Citations (Scopus)

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

DRIVE-FORWARD Study Group, 1 May 2018, In : The Lancet HIV. 5, 5, p. e211-e220

Research output: Contribution to journalArticleResearchpeer-review

Ritonavir
HIV-1
Reverse Transcriptase Inhibitors
Nucleosides
HIV Infections

MTM Economics 101: Supply vs. demand

Clay, P. G., 1 Mar 2018, In : Journal of the American Pharmacists Association. 58, 2, p. 228-229 2 p.

Research output: Contribution to journalArticleResearchpeer-review

Economics

Do you want to matter?

Clay, P. G., 1 Nov 2017, In : Journal of the American Pharmacists Association. 57, 6, 1 p.

Research output: Contribution to journalArticleResearchpeer-review

Professional Role
Pharmaceutical Services
Pharmacists
Research Design